|
Quaternary opioid carboxamides
color: #f5f5f5;
}
2007-076-201
Innovation Summary:
This invention provides a new class of opioid receptor binding compounds designed to ameliorate the peripheral side effects of therapeutic opiates (e.g., constipation, nausea, emesis, pruritis, dysphoria, urinary retention) without interfering with central analgesic activity. The compounds are...
Published: 7/31/2026
|
Updated: 7/1/2026
|
Inventor(s): Mark Wentland
Keywords(s):
Category(s): Biotechnology and the Life Sciences
|
